Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01834924 · ClinicalTrials.gov registry record · NA
Improving Communication of Medication Instructions to Parents
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 1,196
- Enrollment target
NCT01834924 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 1,196 participants.
The verdict
NCT01834924, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,196 participants
- Enrollment target
Study Summary
Almost half of all US adults have trouble understanding and using health information, or low health literacy. Health literacy is considered to be an important patient safety issue, and has been linked to poor medication management. Low health literacy is a risk factor for parent errors in administering medications to their children; difficulty understanding provider medication instructions is likely to contribute to errors. To address these issues, bilingual (English/Spanish), low literacy, picture-based medication instruction sheets were developed. This study will look at the effectiveness and feasibility of the medication instruction sheet-based intervention as it is used by providers in 2 pediatric emergency department settings, as part of a planned roll out of HELPix within the hospital system. The investigators hypothesize that there will be reduced medication dosing errors, improved medication adherence, reduced hospital revisit rates, and improved provider-parent communication. The investigators also hypothesize that provider technology experience, knowledge, and attitudes, will affect the extent to which providers use the tool.
Interventions
- OTHER HELPix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,196 participants |
| Start Date | 2010-05-31 |
| Est. Completion | 2015-01-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01834924
The ClinicalTrials.gov registry entry for NCT01834924 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,196 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which HELPix is the first listed.
NCT01834924 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01834924 about?
NCT01834924 is a clinical study titled "Improving Communication of Medication Instructions to Parents". Almost half of all US adults have trouble understanding and using health information, or low health literacy. Health literacy is considered to be an important patient safety issue, and has been linked to poor medication management. Low health literacy is a risk factor for parent errors in administer...
What is the current status of trial NCT01834924?
This trial is currently completed. It is a NA study. The enrollment target is 1,196 participants. The study started on 2010-05-31. Estimated completion is 2015-01-09.
What interventions are being tested in trial NCT01834924?
The interventions under investigation include: HELPix (OTHER).
Who is sponsoring clinical trial NCT01834924?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.